Assessing remote monitoring functions in pacemakers
Official title: Clinical Assessment of Essential Remote Monitoring Functions in Pacemakers
Run by MicroPort CRM · NCT05165095 · Data updated 2026-11-12
This study is testing how well remote monitoring features in certain pacemakers work to keep patients safe over four years after their surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 206 (estimated) |
| Sponsor | MicroPort CRM Industry-sponsored |
| Locations | 19 sites (Krems and 18 other locations) |
| Status | Recruiting |
| Started | March 25, 2022 |
| Main results expected | September 5, 2023 |
| Study ends | July 2027 |
| Registry record updated | May 31, 2024 |
| Trial ID | NCT05165095 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients who have recently received an ALIZEA, BOREA, or CELEA dual chamber pacemaker and are eligible for remote monitoring.
✕Probably not a fit
Patients with elevated RV pacing thresholds, permanent atrial fibrillation, or those enrolled in conflicting clinical investigations may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical investigation aims to evaluate the safety and performance of remote monitoring functions in the ALIZEA, BOREA, and CELEA pacemakers. Patients will be monitored for 48 months following implantation, with assessments conducted during scheduled follow-up visits. The study will measure the effectiveness of remote alerts and other monitoring features, ensuring patient safety throughout the duration of the investigation.
Why it matters
Potential benefit: If successful, this study could enhance the management of patients with bradycardia by improving the effectiveness of remote monitoring in pacemakers.
How similar studies have gone: Previous studies have shown promise in remote monitoring of cardiac devices, suggesting potential for success in this investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patient implanted according to the most recent guidelines from the ESC, for 20 days or less (de novo implantation, device upgrade to dual chamber or device replacement) 2. Patient implanted with an ALIZEA, BOREA or CELEA dual chamber pacemaker from MicroPort CRM 3. Patient implanted with any active or passive CE marked bipolar RA lead, and any active or passive CE marked bipolar RV lead 4. Patient's pacemaker with the remote monitoring functions (i.e. the RAAT, the RVAT and the remote alerts) accepted by the patient and planned to be activated 5. Patient reviewed, signed and dated the ICF Exclusion Criteria: 1. Patient with an elevated RV pacing threshold (strictly above 2.0 V for a pulse width of 0.5 ms or below) 2. Patient with permanent AF 3. Patient already enrolled in another clinical investigation that could confound the results of this clinical investigation (e.g., clinical investigations involving intra-cardiac device) 4. Patient implanted despite a contraindication for cardiac pacing system implantation (i.e. patient implanted with a defibrillator, patient contraindicated for a single dose of 310 μg of dexamethasone sodium phosphate, patient implanted with a tricuspid replacement heart valve or with a significant tricuspid valve disease that may lead to future replacement heart valve surgery) 5. Minor age patient (i.e. under 18 years of age) 6. Incapacitated patient, under guardianship, kept in detention, refusing to cooperate or not able to understand the purpose of this clinical investigation 7. Patient unavailable for the follow-up visits scheduled 8. Non-menopausal women
Where it's running
-
Universitätsklinikum Krems
Krems, Austria Recruiting -
Allgemeines Krankenhaus Wien
Vienna, Austria Recruiting -
Clinique Saint Joseph
Arlon, Belgium Recruiting -
CHU Bordeaux
Bordeaux, France Recruiting -
CH Chartres
Le Coudray, France Recruiting -
CHU Hôpital de la Timone
Marseille, France Recruiting
Show 13 more locations
-
CHU Nantes
Nantes, France Recruiting -
Clinique Pasteur Toulouse
Toulouse, France Recruiting -
CH Valence
Valence, France Recruiting -
Cardiologicum Hamburg
Hamburg, Germany Recruiting -
Cardiologicum Pirna
Pirna, Germany Recruiting -
Kardiologische Praxis Dr. Trautwein & Dr. Placke
Rostock, Germany Recruiting -
Ziekenhuis VieCuri Venlo
Venlo, Netherlands Recruiting -
Hospital Professor Doutor Fernando Fonseca
Amadora, Portugal Recruiting -
Hospital Arquitecto Marcide
Ferrol, Spain Recruiting -
Hospital Universitario Puerta de Hierro
Majadahonda, Spain Recruiting -
Kingston Hospital
London, United Kingdom Recruiting -
Southend University Hospital
Westcliff-on-Sea, United Kingdom Recruiting -
Basildon University Hospital
Basildon, United Kingdom Not yet recruiting
Study contacts
- Study coordinator: Antoine Guihard
- Email: antoine.guihard@crm.microport.com
- Phone: +33 1 46 01 33 20
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SPIKE FLOW endocardial pacing lead safety and performance study
This study tests whether the SPIKE FLOW temporary endocardial pacing lead is safe and effective in adults needing temporary pacing during heart-related conditions.
-
Factors Linked to Slow Heart Rate After Pulsed Field Ablation for Atrial Fibrillation
This study looks for factors that might cause bradycardia during the hospital stay after AF ablation using pulsed field technology.
-
Transjugular implantation of a leadless pacemaker (Aveir VR) for ventricular pacing
This study tests whether placing an Aveir VR leadless pacemaker through the neck vein can safely provide ventricular pacing in adults with bradycardia.
-
Conduction System Pacing Display Research During LBBAP Implant
Researchers are testing a CSP Display System during left bundle branch area pacing pacemaker implant to see if it accurately shows heart signals compared with a standard ECG.
-
Focal Cryoablation vs. Radiofrequency Cardioneuroablation for Bradyarrhythmias
This study tests whether focal cryoablation can treat vagally driven slow heart rhythms as well as traditional radiofrequency ablation in adults with bradycardia or related syncope.
-
Personalized pacing rate to see if higher lower rate helps heart and brain flow
In hypertensive patients with bradycardia who need a dual-chamber pacemaker, the study tests whether setting a higher, personalized pacing rate improves heart function and brain blood flow compared with the standard 60 bpm.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.